允许工具 / xhigh / 框架未记录 · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · 允许工具 / xhigh / 框架未记录 · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
允许工具 / 推理预算未记录 / Pro harness · GeneBench full suite; separately reported GPT Pro harness; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · 允许工具 / 推理预算未记录 / Pro harness · GeneBench full suite; separately reported GPT Pro harness; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
允许工具 / none / 框架未记录 · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · 允许工具 / none / 框架未记录 · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
允许工具 / low / 框架未记录 · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · 允许工具 / low / 框架未记录 · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
允许工具 / medium / 框架未记录 · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · 允许工具 / medium / 框架未记录 · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
允许工具 / high / 框架未记录 · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · 允许工具 / high / 框架未记录 · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
Regular display scope. Rankings are grouped by metric and evaluation protocol. Recorded tool access, budgets, and frameworks are shown separately. Scores remain available for reference when conditions are unspecified.
Mean pass rate %
Tools allowed / xhigh / Framework not recorded · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · Tools allowed / xhigh / Framework not recorded · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
Tools allowed / Reasoning budget not recorded / Pro harness · GeneBench full suite; separately reported GPT Pro harness; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · Tools allowed / Reasoning budget not recorded / Pro harness · GeneBench full suite; separately reported GPT Pro harness; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
Tools allowed / none / Framework not recorded · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · Tools allowed / none / Framework not recorded · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
Tools allowed / low / Framework not recorded · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · Tools allowed / low / Framework not recorded · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
Tools allowed / medium / Framework not recorded · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · Tools allowed / medium / Framework not recorded · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
Tools allowed / high / Framework not recorded · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt
GeneBench · 2026-04-23 report; 103 evaluations across 10 domains · Mean pass rate · Tools allowed / high / Framework not recorded · GeneBench full suite; 103 evaluations across 10 domains; mean unweighted per-problem pass rate over repeated runs; 95% CI in source excerpt